Evidence map›Paper›PMID 25030168›Full record

ArticleNature2014

The cancer glycocalyx mechanically primes integrin-mediated growth and survival.

Matthew J Paszek, Christopher C DuFort, Olivier Rossier, Russell Bainer, Janna K Mouw, Kamil Godula, Jason E Hudak, Jonathon N Lakins, Amanda C Wijekoon, Luke Cassereau and 10 more

Abstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 366 papers.

0numbers the graph read from it
0cells of the map it votes in
366citing papers in PubMed
29.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

366 citing papers in PubMed, 691 citations in OpenAlex.

  1. Article
  2. Engineering CAR-T cells to remodel the mucin-rich cancer cell glycocalyx.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. The protease cathepsin K can debulk the cancer glycocalyx.The Journal of biological chemistry · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Tumor Metastasis in the Microcirculation.Advances in experimental medicine and biology · 2026
    Review
  19. Review
  20. Article

306 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Matthew J Paszek1] Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA [2] Bay Area Physical Sciences-Oncology Program, University of California, Berkeley, California 94720, USA [3] School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, USA [4] Laboratory for Atomic and Solid State Physics and Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York 14853, USA.
Christopher C DuFort1] Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA [2] Bay Area Physical Sciences-Oncology Program, University of California, Berkeley, California 94720, USA.
Olivier Rossier1] Interdisciplinary Institute for Neuroscience, University of Bordeaux, UMR 5297, F-33000 Bordeaux, France [2] CNRS, Interdisciplinary Institute for Neuroscience, University of Bordeaux, UMR 5297, F-33000 Bordeaux, France.
Russell Bainer1] Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA [2] Bay Area Physical Sciences-Oncology Program, University of California, Berkeley, California 94720, USA.
Janna K MouwDepartment of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA.
Kamil Godula1] Department of Chemistry, University of California, Berkeley, California 94720, USA [2] The Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA [3] Department of Chemistry and Biochemistry, University of California, San Diego, California 92093, USA.
Jason E HudakDepartment of Chemistry, University of California, Berkeley, California 94720, USA.
Jonathon N LakinsDepartment of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA.
Amanda C Wijekoon1] Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA [2] Bay Area Physical Sciences-Oncology Program, University of California, Berkeley, California 94720, USA.
Luke Cassereau1] Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA [2] Bay Area Physical Sciences-Oncology Program, University of California, Berkeley, California 94720, USA.
Matthew G Rubashkin1] Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA [2] Bay Area Physical Sciences-Oncology Program, University of California, Berkeley, California 94720, USA.
Mark J Magbanua1] Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA [2] Division of Hematology/Oncology, University of California, San Francisco, California 94143, USA.
Kurt S ThornDepartment of Biochemistry and Biophysics, University of California, San Francisco, California 94158, USA.
Michael W DavidsonNational High Magnetic Field Laboratory and Department of Biological Science, The Florida State University, Tallahassee, Florida 32310, USA.
Hope S Rugo1] Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA [2] Division of Hematology/Oncology, University of California, San Francisco, California 94143, USA.
John W Park1] Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA [2] Division of Hematology/Oncology, University of California, San Francisco, California 94143, USA.
Daniel A HammerDepartments of Chemical and Biomolecular Engineering and Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Grégory Giannone1] Interdisciplinary Institute for Neuroscience, University of Bordeaux, UMR 5297, F-33000 Bordeaux, France [2] CNRS, Interdisciplinary Institute for Neuroscience, University of Bordeaux, UMR 5297, F-33000 Bordeaux, France.
Carolyn R Bertozzi1] Department of Chemistry, University of California, Berkeley, California 94720, USA [2] Department of Molecular Biology, University of California, Berkeley, California 94720, USA [3] Howard Hughes Medical Institute, University of California, Berkeley, California 94720, USA.
Valerie M Weaver1] Department of Surgery and Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, California 94143, USA [2] Bay Area Physical Sciences-Oncology Program, University of California, Berkeley, California 94720, USA [3] Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA [4] Departments of Anatomy and Bioengineering and Therapeutic Sciences and Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, University of California, San Francisco, California 94143, USA.
University of California, San Francisco · USUniversity of California, Berkeley · USUCSF Helen Diller Family Comprehensive Cancer Center · USUniversité de Bordeaux · FRFlorida State University · USPhysical Sciences (United States) · USUniversity of Pennsylvania · US

Funding

TRANS-NETWORK PROJECTSU54CA143836 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI LIPHARDT, JAN T. · 2009 to 2014
$15.1M
Univ of Calif Berkeley Chemistry-Biology Interface ProgramT32GM066698 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, CHRISTOPHER J., FRANCIS, MATTHEW B · 2004 to 2023
$7.5M
Investigations of Golgi EnzymesR01GM059907 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 1999 to 2016
$5.9M
The vascular niche in glioma propagation and resistance to therapyU54CA163155 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BERGERS, GABRIELE, WEAVER, VALERIE MARIE · 2011 to 2015
$4.4M
Role of Fibroblasts, Myeloid Cells and Matrix in PDACU01CA151925 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KALLURI, RAGHU, MOSES, HAROLD L · 2010 to 2014
$3.2M
Simulation of Lymphocyte Adhesion using Integrated Adhesive DynamicsR01AI082292 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HAMMER, DANIEL A · 2009 to 2017
$2.8M
Environmental Effect on the Mammary Gland across the LifespanU01ES019458 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 2010 to 2014
$2.5M
Collagen remodeling and tumor progressionR01CA138818 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEAVER, VALERIE MARIE · 2010 to 2014
$2.0M
NeoProteoglycans as synthetic materials for regenerative medicine and bioimagingR00EB013446 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GODULA, KAMIL · 2013 to 2015
$722k
Spinning disk confocal / FRAP microscope for quantitative live cell imagingS10RR026758 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTMANN, TORSTEN · 2010 to 2010
$500k
NeoProteoglycans as synthetic materials for regenerative medicine and bioimagingK99EB013446 · NIBIB · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI GODULA, KAMIL · 2011 to 2012
$165k
Howard Hughes Medical InstituteNCI NIH HHS CA138818-01A1NCI NIH HHS R01 CA138818NCI NIH HHS U01 CA151925NCI NIH HHS U54 CA143836NCI NIH HHS U54CA143836-01NCI NIH HHS U54 CA163155NCI NIH HHS U54CA163155-01NCRR NIH HHS S10 RR026758NIAID NIH HHS AI082292-03A1NIAID NIH HHS R01 AI082292NIBIB NIH HHS K99 EB013446NIBIB NIH HHS K99 EB013446-02NIBIB NIH HHS R00 EB013446NIEHS NIH HHS 1U01 ES019458-01NIEHS NIH HHS U01 ES019458NIGMS NIH HHS 2R01GM059907-13NIGMS NIH HHS GM59907NIGMS NIH HHS R01 GM059907NIGMS NIH HHS T32 GM066698
6 · The paper itself

Abstract

Malignancy is associated with altered expression of glycans and glycoproteins that contribute to the cellular glycocalyx. We constructed a glycoprotein expression signature, which revealed that metastatic tumours upregulate expression of bulky glycoproteins. A computational model predicted that these glycoproteins would influence transmembrane receptor spatial organization and function. We tested this prediction by investigating whether bulky glycoproteins in the glycocalyx promote a tumour phenotype in human cells by increasing integrin adhesion and signalling. Our data revealed that a bulky glycocalyx facilitates integrin clustering by funnelling active integrins into adhesions and altering integrin state by applying tension to matrix-bound integrins, independent of actomyosin contractility. Expression of large tumour-associated glycoproteins in non-transformed mammary cells promoted focal adhesion assembly and facilitated integrin-dependent growth factor signalling to support cell growth and survival. Clinical studies revealed that large glycoproteins are abundantly expressed on circulating tumour cells from patients with advanced disease. Thus, a bulky glycocalyx is a feature of tumour cells that could foster metastasis by mechanically enhancing cell-surface receptor function.

Indexed as

AnimalsBreastCell Line, TumorCell ProliferationCell SurvivalFibroblastsGlycocalyxGlycoproteinsHumansImmobilized ProteinsIntegrinsMiceMolecular Targeted TherapyMucin-1Neoplasm MetastasisNeoplasmsGlycoproteinsImmobilized ProteinsIntegrinsMucin-1Receptors, Cell Surface

Identifiers

PMID25030168
PMCPMC4487551
OpenAlexW1970811697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.